{"organizations": [], "uuid": "8a9a1f7059087f37471c21cdab397214418a4496", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180108.html", "section_title": "Archive News &amp; Video for Monday, 08 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-saniona-reports-results-from-tesom/brief-saniona-reports-results-from-tesomet-phase-2a-interim-study-in-prader-willi-syndrome-idUSFWN1P3022", "country": "US", "domain_rank": 408, "title": "BRIEF-Saniona Reports Results From Tesomet Phase 2A Interim Study In Prader-Willi Syndrome", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.44, "site_type": "news", "published": "2018-01-08T15:13:00.000+02:00", "replies_count": 0, "uuid": "8a9a1f7059087f37471c21cdab397214418a4496"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-saniona-reports-results-from-tesom/brief-saniona-reports-results-from-tesomet-phase-2a-interim-study-in-prader-willi-syndrome-idUSFWN1P3022", "ord_in_thread": 0, "title": "BRIEF-Saniona Reports Results From Tesomet Phase 2A Interim Study In Prader-Willi Syndrome", "locations": [], "entities": {"persons": [{"name": "saniona", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 8 (Reuters) - SANIONA AB:\n* REG-SANIONA AB: SANIONA REPORTS TOP LINE RESULTS FROM THE TESOMET PHASE 2A INTERIM STUDY IN PRADER-WILLI SYNDROME\n* ‍PLASMA CONCENTRATIONS OF TESOFENSINE WERE FOUND TO BE 2 TO 4 TIMES HIGHER IN THIS STUDY COMPARED TO PREVIOUS STUDIES​\n* ‍SAYS RESULTS MUST BE INTERPRETED WITH CAUTION​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-08T15:13:00.000+02:00", "crawled": "2018-01-09T17:16:38.010+02:00", "highlightTitle": ""}